MaxCyte (MXCT) Competitor Comparison
We are evaluating the key criteria listed to compare MaxCyte (MXCT) against its competitors in the Diagnostics & Research industry.
Market Capitalization
36 / 58Gross Profits
40 / 52Total Revenue
46 / 57EBITDA
45 / 56Free Cashflow
44 / 56Quick Ratio
3 / 57Earnings per Share
27 / 56Dividend yield
0 / 9Total Cash
27 / 57Performance 3 years
41 / 58Performance 5 years
47 / 58Performance 10 years
43 / 58Linearity 3 years
37 / 58Linearity 5 years
48 / 58Linearity 10 years
29 / 58Total Rank
20 / 58Dividend Rank
58 / 58Valuation Rank
26 / 58Piotroski Rank
47 / 58Muliplier Rank
51 / 58Dividend yield - MXCT ranking 0 / 9
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.